Furthermore, GSVA and GSEA‐HALLMARKER analyses revealed that DCTN2 was positively associated with tumour‐promoting pathways such as the PI3K/AKT/mTOR pathway, MYC_targets, and E2F_targets, indicating that DCTN2 was significantly related to various tumour‐related pathways (Figure 7F,G). Here, MTOR is linked to neoplasm.